Article Details

Cowen Reaffirms “Buy” Rating for Syros Pharmaceuticals (SYRS)

Retrieved on: 2018-08-09 07:34:42

Tags for this article:

Click the tags to see associated articles and topics

Cowen Reaffirms “Buy” Rating for Syros Pharmaceuticals (SYRS). View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP raised its holdings in shares of Syros Pharmaceuticals by 80.3% in the fourth quarter. <b>Two Sigma Investments</b> LP now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up